SPATA13 and Alzheimer disease: SPATA13 has a plausible association with AD because of its enriched expression within the central extended amygdala (Becker et al., 2008) and the link between atrophy of the amygdala and early AD onset and severity of symptoms (Poulin et al., 2011).